Advertisement

Journal of Inherited Metabolic Disease

, Volume 9, Issue 4, pp 405–406 | Cite as

Phenylketonuria and scleroderma

  • E. H. Brown
  • H. K. Berry
  • J. Olson
  • J. Levinson
Case Report

Keywords

Public Health Internal Medicine Metabolic Disease Scleroderma Phenylketonuria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Drummond, K. N., Michael, A. F. and Good, R. A. Tryptophan metabolism in a patient with phenylketonuria and scleroderma: a proposed explanation of the indole effect in phenylketonuria.Can. Med. Assoc. J. 94 (1966) 834–838Google Scholar
  2. Guillet, G. Y., Dore, N., Hehunstre, J. P., Maleville, J. and Battin, J. Pseudoscleroderma and phenylketonuria.Int. J. Dermatol. 22 (1983) 422–426Google Scholar
  3. Nishimura, N., Okamoto, H., Yasui, M., Maeda, K. and Ogura, K. Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. II. Influences of the low phenylalanine and tyrosine diet upon patients with collagen diseases.Am. Med. Assoc. Arch. Dermatol. 80 (1959) 466–477Google Scholar

Copyright information

© SSIEM and MTP Press Limited 1986

Authors and Affiliations

  • E. H. Brown
    • 1
  • H. K. Berry
    • 1
  • J. Olson
    • 2
  • J. Levinson
    • 2
  1. 1.Metabolic Disease CenterChildren's Hospital Medical CenterCincinnatiUSA
  2. 2.Special Treatment Center for Juvenile ArthritisChildren's Hospital Medical CenterCincinnatiUSA

Personalised recommendations